
Benitec Biopharma Releases Third Quarter 2025 Financial Results
(MENAFN- GlobeNewsWire - Nasdaq) HAYWARD, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or“Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its …